Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2003, Vol. 8 ›› Issue (1): 1-5.

    Next Articles

Inhibitory effects and mechanisms of iptkalim on the glutamate release from PC12 cells induced by high K+1

YAO Hong-Hong, ZHANG Yun, DING Jian-Hua, LIU Su-Yi, WANG Hai2, HU Gang   

  1. Department of Pharmacology and Neurobiology, Nanjing Medical University, Nanjing 210029, Jiangsu; 2 Insititute of Pharmacology and Toxicology, Academy of Military Medical Science, Beijing 100850
  • Received:2002-10-07 Revised:2002-10-25 Published:2020-11-25

Abstract: AIM: To study the effects and mechanisms of ATP-sensitive potassium channel (KATP) opener iptkalim (IPT) on the glutamate release from cultured PC12 cells induced by high K +. METHODS: The glutamate release from cultured PC12 cells was measured by using HPLC combined with fluorescent detector analysis. RESULTS: Different concentrations of IPT (0.01, 0.10, 1.00, 10.0, 100 μmol·L -1) were shown to inhibit glutamate release from PC12 cells induced by high K + in a concentration-dependent manner, and these inhibitory effects were partly reversed by KATP blocker glibenclamide (Gli), an inhibitor of KATP channel.Incubation with 1.00 μmol·L -1 Gli alone increased the glutamate release induced by high K +, but selective PKC inhibitor HA-100 and calmodulin (CaM) antagonist trifluoperazine failed to affect the increment of glutamate release. CONCLUSION: Inhibition of glutamate release by IPT is partly reversed by Gli, indicating that the effect of IPT is mediated by the opening of the KATP channel;PKC and CaM are not involved in the increment of glutamate release by Gli.These results demonstrate that KATP channel is implicated in modulating glutamate release.

Key words: pharmacology, HPLC, iptkalim, ATPsensitive potassium channel, PC12 cells, glutamate, calmodulin, glibenclamide

CLC Number: